Unique ID issued by UMIN | UMIN000043525 |
---|---|
Receipt number | R000049697 |
Scientific Title | A pilot study to identify the prevention of food allergy by administering synbiotics to pregnant women and newborns |
Date of disclosure of the study information | 2021/03/05 |
Last modified on | 2021/03/04 21:30:45 |
A pilot study to identify the prevention of food allergy by administering synbiotics to pregnant women and newborns
A study to identify the prevention of food allergy by the administration of synbiotics
A pilot study to identify the prevention of food allergy by administering synbiotics to pregnant women and newborns
A study to identify the prevention of food allergy by the administration of synbiotics
Japan |
food allergy
Pediatrics |
Others
NO
To investigate the efficacy of synbiotics on preventing the development of food allergy in a population at high risk of developing a food allergy.
Efficacy
Differences and changes in the type and diversity of intestinal microflora in children at 4 months of age
(1)Presence of immediate food allergy at 1 year of age
(2)Changes in short-chain fatty acids in the blood
(3)Differences and changes in the types and diversity of breast milk and skin flora
(4)Sensitization to food allergen at 1 year of age
(5)Presence and severity of eczema at 1 year of age
(6)Stratify results affected by mode of delivery, method of child nutrition, and child skin condition
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
3
Prevention
Food |
In intervention group A, pregnant women consume synbiotics (Lactobacillus rhamnosus GG, Bifidobacterium bifidum, and 1-kestose) daily from 34-35 weeks gestation until postpartum day 5, and newborns from day 0 to day 5.
In intervention group B, newborns will take synbiotics (Lactobacillus rhamnosus GG, Bifidobacterium bifidum, 1-kestose) from day 0 to day 5.
In a non-intervention group, participants will not take synbiotics
Not applicable |
Not applicable |
Male and Female
1. Pregnant women at 34 to 35 weeks gestation
2. Either the pregnant woman or her partner has one or more of the following allergic diseases: atopic dermatitis, bronchial asthma, food allergy, allergic rhinitis, allergic conjunctivitis
3. A child born on day 0 to a pregnant woman who meets the above criteria 1 and 2.
1.The pregnant woman who has an obvious underlying medical condition
2.Twins
3.Premature birth or low birth weight infant
4.Severe neonatal asphyxia (Apgar score <4)
5.Children deemed by their doctor to be unsuitable for participation in the study
60
1st name | Noriyuki |
Middle name | |
Last name | Yanagida |
National Hospital Organization Sagamihara National Hospital
Department of pediatrics
252-0392
18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan
042-742-8311
yana@foodallergy.jp
1st name | Yoko |
Middle name | |
Last name | Miura |
National Hospital Organization Sagamihara National Hospital
Department of pediatrics
252-0392
18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan
042-742-8311
yoko6299@gmail.com
National Hospital Organization Sagamihara National Hospital
none
Other
Technical Research Laboratory Takanashi MilkProducts Co. Ltd. Japan
National Hospital Organization Sagamihara National Hospital
18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392
042-742-8311
222-rinri@mail.hosp.go.jp
NO
2021 | Year | 03 | Month | 05 | Day |
Unpublished
Open public recruiting
2020 | Year | 12 | Month | 10 | Day |
2020 | Year | 12 | Month | 18 | Day |
2021 | Year | 02 | Month | 26 | Day |
2024 | Year | 03 | Month | 31 | Day |
2021 | Year | 03 | Month | 04 | Day |
2021 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049697